Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

Also called NCT02064764

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 102 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02064764
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02064764. Randomized; no masking; primary purpose treatment. Start 2015-02 (actual); primary completion 2021-04-19 (actual). Results posted on 2024-02-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation
Acronym
Symplicity AF
Condition
Hypertension
Intervention (Device)
Symplicity Spyral™ Multi-Electrode Renal Denervation Catheter
Intervention (Device)
Arctic Front Advance™ Cardiac Cryoablation System
Lead sponsor
Medtronic Vascular (class: industry)

Record details

Record id
cardio:ct-nct02064764
Content hash
e54a91f757acd4a5f9375a59fcda9e2c17001081f12e3880f2477de03e9a3214